Viatris Launches Tender Offer to Acquire Pacira BioSciences for $36.50 a Share

• Viatris commenced a tender offer on Oct. 30, 2026, to acquire all outstanding Pacira BioSciences common shares for $36.50 each in cash.
• The offer expires one minute after 11:59 p.m. Eastern Time on Nov. 16, 2026, unless extended or terminated earlier.
• Completion requires more than 50% of outstanding shares, antitrust clearance and no legal restraints; the offer has no financing condition.
• Pacira will become a wholly owned subsidiary following completion of the offer and subsequent merger.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viatris Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610300840PR_NEWS_USPR_____NE85051) on October 30, 2026, and is solely responsible for the information contained therein.